Dr Deus Mubangizi, Director, Health Products Policy and Standards Department, World Health Organization. It will be important to understand the process we went through. For critical reviews, if we need more expertise, we issue a call. In this case, because of the nature of the request, we issued an open call for experts. A number …
CND Sessions
Side event: Principles on drug treatment as alternatives to conviction or punishment
Candice Welsh, UNODC. Drug use conditions are health issues. Scientific evidence based treatment improves health outcomes and benefits communities in multiple ways. Alternatives to incarceration are in line to international drug conventions and improve health, wellbeing and public safety. In 2015, UNODC launched its first handbook on the subject. This is where the implementation principles …
Reconvened 68th session of the Commission on Narcotic Drugs – 4 December 2025 morning
4: Joint reconvened 68th CND / 34th CCPCJ: Strategic management, budgetary and administrative questions Chair CCPCJ: Welcome. We will jointly Chair with the CND Chair. We are broadcast on UN Web TV. Let us proceed with consideration of the annotated agenda. Can we agree? United States: The US objects to Item 10 in the provisional …
Side event: Reintegration of persons released from detention or subjected to non-custodial measures
Mr. Simon Walker, OHCHR. Good morning! I am Simon Walker, Chief of the Rule of Law and Democracy Section of the Office of the United High Commissioner for Human Rights. OHCHR is pleased to organise this special event in collaboration with Costa Rica, Colombia, South Africa and Switzerland, the Global Campus of Human Rights, the Penal …
Plenary – Friday afternoon session
Item 11. Other Business Chair: Excellencies, distinguished delegates, ladies and gentlemen. We will now resume from where we had closed the session before lunch by adopting L10 and we will now proceed to the consideration of L6 rev. 1 as amended by L10. Is the commission ready to adopt L6 rev 1 as amended …
Plenary – Friday morning session
CND Chair. Today is the last day of our deliberations. Before we start, it’s wonderful to see you all here again. We had 4 days of productive, engaging discussions, wide-ranging conversations on a wide range of issues. We heard from CSOs and other stakeholders, and you had productive and meaningful deliberations. I will only make …